Impact News +++ APLD′s Energy Strategy is Evolving: Can it Drive Further Upside? (Zacks) +++ APPLIED DIGITAL Aktie -3,49%

VERTEX PHARMACEUTICALS Aktie

>VRTX Aktienkurs

416.25 EUR +6.4% (TradegateBSX)

Ask: 418.2 EUR / 125 Stück

Bid: 416.85 EUR / 125 Stück

Tagesumsatz: 522 Stück

Realtime Kurs von 7:30 bis 22 Uhr!

VRTX Aktie über LYNX handeln

Intraday

1 Jahr

>VRTX Performance

1 Woche: +1,3%

1 Monat: -0,1%

3 Monate: +4,6%

6 Monate: +18,3%

1 Jahr: -9,4%

laufendes Jahr: +0,3%

>VERTEX PHARMACEUTICALS Aktie

Name:

VERTEX PHARMACEUTICALS

Land:

USA

Sektor:

Gesundheit

ISIN/ Wkn:

US92532F1003 / 882807

Symbol/ Ticker:

VX1 (Frankfurt) / VRTX (NASDAQ)

Kürzel:

FRA:VX1, ETR:VX1, VX1:GR, NASDAQ:VRTX

Index:

S&P500, Nasdaq100

Webseite:

https://www.vrtx.com/

Profil:

Vertex Pharmaceuticals Incorporated is a leading biotechnology company founded in 1989 and headquart..
>Volltext..

Marktkapitalisierung:

100398.41 Mio. EUR

Unternehmenswert:

96592.76 Mio. EUR

Umsatz:

9861.8 Mio. EUR

EBITDA:

3989.51 Mio. EUR

Nettogewinn:

3088.46 Mio. EUR

Gewinn je Aktie:

12.04 EUR

Schulden:

1541.92 Mio. EUR

Liquide Mittel:

4158.01 Mio. EUR

Operativer Cashflow:

3124.51 Mio. EUR

Bargeldquote:

1.41

Umsatzwachstum:

4.87%

Gewinnwachstum:

Dividende je Aktie:

Dividendenrendite:

Dividendenschätzung:

Insiderhandel:

5 Insider verkauften innerhalb der letzten 30 Tage Aktien im Wert von 3.471.182 USD.

Suchwörter:

VERTEX PHARMACEUTICALS, VERTEX PHARMA, VRTX

Letzte Datenerhebung:

13.02.26

>VRTX Kennzahlen

Aktien/ Unternehmen:

Aktien: 253.72 Mio. St.

Frei handelbar: 99.66%

Leerverk. Aktien: 1.74%

Rückkaufquote: 1.84%

Mitarbeiter: 6100

Umsatz/Mitarb.: 1.51 Mio. EUR

Analysten:

Analystenrating: Buy

Kursziel: 12.1%

Bewertung:

KGV: 32.65

KGV lG: 25.09

KUV: 10.5

KBV: 6.79

PEG-Ratio: -

EV/EBITDA: 24.21

Rentabilität:

Bruttomarge: 86.29%

Gewinnmarge: 31.32%

Operative Marge: 38.76%

Managementeffizenz:

Gesamtkaprendite: 15.6%

Eigenkaprendite: 22.31%

>VRTX Peer Group

Gesundheit

>VRTX Chart & Kurs - NASDAQ

>VRTX News

13.02.26 - 06:13	Vertex Pharmaceuticals (VRTX) Stock Drops After Hours — Here′s Why It′s Trending Tonight (Benzinga)
	Vertex Pharmaceuticals shares dipped 1.24% in after-hours trading Thursday despite reporting a 10% rise in fourth-quarter revenue to $3.19 billion. Importance Rank: 1 read more...

13.02.26 - 01:45	Vertex (VRTX) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
	Although the revenue and EPS for Vertex (VRTX) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers....

13.02.26 - 01:01	Insiderhandel: SVP & Chief Accounting Officer verkauft Aktien von Vertex Pharmaceuticals im Wert von 633552 USD (Insiderkauf)
	Ambrose, Kristen - Vorstand - Tag der Transaktion: 2026-02-11...

13.02.26 - 01:01	Insiderhandel: EVP, Chief Technical Ops. Off. verkauft Aktien von Vertex Pharmaceuticals im Wert von 806213 USD (Insiderkauf)
	Atkinson, Edward Morrow III. - Vorstand - Tag der Transaktion: 2026-02-11...

13.02.26 - 01:01	Insiderhandel: EVP and Chief Legal Officer verkauft Aktien von Vertex Pharmaceuticals im Wert von 886328 USD (Insiderkauf)
	Biller, Jonathan - Vorstand - Tag der Transaktion: 2026-02-11...

13.02.26 - 01:01	Insiderhandel: EVP, Chief Scientific Officer verkauft Aktien von Vertex Pharmaceuticals im Wert von 930529 USD (Insiderkauf)
	Bunnage, Mark E. - Vorstand - Tag der Transaktion: 2026-02-11...

13.02.26 - 01:01	Insiderhandel: EVP, Chief Reg. & Quality Off. verkauft Aktien von Vertex Pharmaceuticals im Wert von 214560 USD (Insiderkauf)
	Tatsis, Ourania - Vorstand - Tag der Transaktion: 2026-02-11...

13.02.26 - 01:00	Vertex Pharmaceuticals (VRTX) Q4 Earnings Miss Estimates (Zacks)
	Vertex (VRTX) delivered earnings and revenue surprises of -0.74% and +0.70%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?...

13.02.26 - 00:24	Vertex (VRTX) Q4 2025 Earnings Call Transcript (Fool)
	Um den gesamten Artikel unter fool.com zu lesen, klicken Sie bitte auf die Überschrift...

12.02.26 - 22:36	Vertex Pharmaceuticals Inc. Reports Rise In Q4 Bottom Line (AFX)
	CAMBRIDGE (MASSACHUSETTS) (dpa-AFX) - Vertex Pharmaceuticals Inc. (VRTX) reported earnings for its fourth quarter that Increases, from last yearThe company's earnings came in at $1.191 billion, or......

12.02.26 - 22:09	Vertex Pharmaceuticals Non-GAAP EPS of $5.03 misses by $0.12, revenue of $3.19B beats by $20M (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

12.02.26 - 22:03

Vertex Reports Fourth Quarter and Full Year 2025 Financial Results (Business Wire)

— Full year total revenue of $12.0 billion, a 9% increase compared to full year 2024; fourth quarter total revenue of $3.19 billion, a 10% increase compared to fourth quarter 2024 — — Company provides full year 2026 total revenue guidance of $12.95 billion to $13.1 billion, with non-CF products expected to contribute $500 million or more in revenue — — Broad mid- and late-stage clinical pipeline accelerates with multiple proof-of-concept and pivotal programs advancing; on track to complete BLA filing for U.S. accelerated approval of povetacicept in IgAN in the first half of 2026 —BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today reported consolidated financial results for the fourth quarter and full year ended December 31, 2025, and provided its full year 2026 financial guidance. “2025 marked a year of strong revenue growth, commercial diversification, and pipeline advancement,” said Reshma Kewalramani, M.D., Chief Executive Officer and President of Vertex. ...

12.02.26 - 18:03	Vertex Pharmaceuticals Aktie: Neuer CEO setzt auf Innovation - aber keine Katalysatoren für den großen Sprung! (Aktiencheck)
	Great Falls (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von D.A. Davidson & Co.: D.A. Davidson & Co. habe das Kursziel für die Aktie von Vertex Pharmaceuticals Inc. (ISIN: US92532F1003, WKN: 882807, Ticker-Symbol: VX1, NASDAQ-Symbol: VRTX) von 23 auf 13 USD gesenkt und das "neutral"-Rating für die Aktie beibehalten. [mehr]...

10.02.26 - 20:00	1 Reason I′d Buy Vertex Pharmaceuticals Stock and Never Sell (Fool)
	Vertex stock has climbed more than 60% over three years....

10.02.26 - 18:15	Vertex Gears Up to Report Q4 Earnings: Is a Beat in the Cards? (Zacks)
	VRTX is set to report Q4 results amid strong Trikafta demand. Alyftrek launches are gaining traction while investors are eyeing Casgevy and Journavx sales....

09.02.26 - 20:24	Should You Buy Vertex Pharmaceuticals Before Feb. 12? (Fool)
	The next 12 months will be important for the drugmaker....

09.02.26 - 19:00	Will These 5 Drug Bigwigs Surpass Q4 Earnings Forecasts? (Zacks)
	Let's look at five pharma and biotech companies, AZN, INCY, GILD, VRTX and MRNA, which are scheduled to release their fourth-quarter 2025 results this week....

09.02.26 - 16:45	Seeking Clues to Vertex (VRTX) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics (Zacks)
	Evaluate the expected performance of Vertex (VRTX) for the quarter ended December 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight....

05.02.26 - 17:30	Vertex Pharmaceuticals (VRTX) Earnings Expected to Grow: What to Know Ahead of Next Week′s Release (Zacks)
	Vertex (VRTX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations....

04.02.26 - 04:00	WUXI BIO, Vertex Pharmaceuticals Sign License & Research Service Agreement for T-cell Engager (AAStocks)
	Um den gesamten Artikel unter aastocks.com zu lesen, klicken Sie bitte auf die Überschrift...

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Weiber lächeln, wenn sie grüßen. - Jean Paul

Partner: >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram